Skip to content

Impact of Intrathecal Morphine on Sleep Apnea Syndrome

Impact of Intrathecal Morphine on Sleep Apnea Syndrome After Hip Arthroplasty Performed Under Spinal Anaesthesia

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02566226
Enrollment
60
Registered
2015-10-02
Start date
2015-11-30
Completion date
2019-03-31
Last updated
2019-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea Syndromes

Brief summary

Intrathecal morphine is commonly used as an analgesic adjunct for hip arthroplasty performed under spinal anaesthesia. Sleep apnea syndrome is a condition that affects up to 10% of the patients. Effect of intrathecal hydrophilic opioids on the frequency and duration of apneic episodes is unknown. The objective of this randomised controlled trial is to investigate the effect of intrathecal morphine and surgery on apneic episodes.

Interventions

DRUGBupivacaine with normal saline

Isobaric bupivacaine 15 mg + normal saline 0.5 cc

DRUGBupivacaine with intrathecal morphine

Isobaric bupivacaine 15 mg + intrathecal morphine 100 mcg

Sponsors

Centre Hospitalier Universitaire Vaudois
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

* physical status I - III * patients scheduled to undergo hip arthroplasty

Exclusion criteria

* planned surgical duration more than 3 hours * contraindication to spinal anaesthesia * severe respiratory disease * patient known and treated for sleep apnea syndrome

Design outcomes

Primary

MeasureTime frame
apnea hypopnea index while lying supinepostoperative night 0

Secondary

MeasureTime frame
mean pulse oxymetrypostoperative night 0
STOP-BANG questionnaire24 h before surgery
Berlin questionnaire24 h before surgery
Epworth questionnaire24 h before surgery
apnea hypopnea index while lying in another position than supinepostoperative night 0
oxycodone consumption (mg)postoperative day 0, 1, 2 and 3
postoperative nausea and vomiting (yes/no)postoperative day 0, 1, 2 and 3
Pruritus (yes/no)postoperative day 0, 1, 2 and 3
pain scores (numeric rating scale, 0-10)postoperative day 0, 1, 2 and 3

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026